Using combined peptide quantification by PRM showed that measuring an increased C:N‐terminal peptide ratio is a sensitive and highly specific marker for ALS TDP‐43 pathology in brain. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.